Showing results (1-10 of 224) with videos related to

Sort By:
Pageof 23
JAMA Ophthalmology|March 23, 2018
Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Medication UseMarie Thulliez, Denis Angoulvant, Pierre-Jean Pisella, et al.
Basic Research in Cardiology|February 6, 2015
Remote ischemic conditioning and cardioprotection: a systematic review and meta-analysis of randomized clinical trialsSophie Le Page, Theodora Bejan-Angoulvant, Denis Angoulvant, et al.
Thrombosis and Haemostasis|September 2, 2016
Risk of myocardial infarction and death in patients with atrial fibrillation treated with dabigatran or vitamin K antagonists. Meta-analysis of observational analysesWalid Darwiche, Theodora Bejan-Angoulvant, Denis Angoulvant, et al.
Scientific Reports|September 8, 2017
Revisiting myocardial necrosis biomarkers: assessment of the effect of conditioning therapies on infarct size by kinetic modellingDavid Ternant, Fabrice Ivanes, Fabrice Prunier, et al.
Archives of Cardiovascular Diseases|December 3, 2014
Ischaemic postconditioning reduces infarct size: systematic review and meta-analysis of randomized controlled trialsCaroline Touboul, Denis Angoulvant, Nathan Mewton, et al.
JAMA Ophthalmology|April 15, 2021
Cardiovascular Adverse Events With Intravitreal Anti-Vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Clinical TrialsNadège Ngo Ntjam, Marie Thulliez, Gilles Paintaud, et al.
Medecine Sciences : M/S|January 7, 2020
[Mechanism of action and adverse effects of monoclonal antibodies]Theodora Bejan-Angoulvant, Joachim Alexandre
Chest|March 27, 2015
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation ProjectDenis Angoulvant, Olivier Villejoubert, Theodora Bejan-Angoulvant, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 21, 2012
Myocardial microvascular disease and major adverse cardiovascular events in patients with end-stage renal disease: rationale and design of the MICROCARD studyTheodora Bejan-Angoulvant, Cyrille Bergerot, Laurent Juillard, et al.
Presse Medicale (Paris, France : 1983)|November 17, 2019
[Endogenous and exogenous estrogens]Theodora Bejan-Angoulvant, Jean-Francois Arnal
Pageof 23